Download PDF
Thorac Cardiovasc Surg 2017; 65(08): 612-616
DOI: 10.1055/s-0034-1399783
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

Tricuspid Valve Repair for the Poor Right Ventricle: Tricuspid Valve Repair in Patients with Mild-to-Moderate Tricuspid Regurgitation Undergoing Mitral Valve Repair Improves In-Hospital Outcome

Alicja Zientara
1   Department of Cardiac Surgery, Stadtspital Triemli, Zürich, Switzerland
,
Michele Genoni
1   Department of Cardiac Surgery, Stadtspital Triemli, Zürich, Switzerland
,
Kirk Graves
1   Department of Cardiac Surgery, Stadtspital Triemli, Zürich, Switzerland
,
Dragan Odavic
1   Department of Cardiac Surgery, Stadtspital Triemli, Zürich, Switzerland
,
Helen Löblein
1   Department of Cardiac Surgery, Stadtspital Triemli, Zürich, Switzerland
,
Achim Häussler
1   Department of Cardiac Surgery, Stadtspital Triemli, Zürich, Switzerland
,
Omer Dzemali
1   Department of Cardiac Surgery, Stadtspital Triemli, Zürich, Switzerland
› Author Affiliations
Further Information

Publication History

25 September 2014

28 November 2014

Publication Date:
28 January 2015 (online)

    Permissions and Reprints All articles of this category

Abstract

Background Tricuspid regurgitation (TR) in patients undergoing surgery for mitral valve (MV) increases morbidity and mortality, especially in case of a poor right ventricle. Does repair of mild-to-moderate insufficiency of the tricuspid valve (TV) in patients undergoing MV surgery lead to a benefit in early postoperative outcome?

Methods A total of 22 patients with mild-to-moderate TR underwent MV repair and concomitant TV repair with Tri-Ad (Medtronic ATS Medical Inc., Minneapolis, Minnesota, United States) and Edwards Cosgrove (Edwards Lifesciences Irvine, California, United States) rings. The severity of TR was assessed echocardiographically by using color-Doppler flow images. The tricuspid annular plane systolic excursion (TAPSE) was under 1.7 cm. Additional procedures included coronary artery bypass (n = 9) and maze procedure (n = 15). The following parameters were compared: postoperative and peak dose of noradrenaline (NA), pre/postoperative systolic pulmonary pressure (sPAP), extubation time, operation time, cross-clamp time, cardiopulmonary bypass (CPB) time, pre/postoperative ejection fraction (EF), intensive care unit (ICU)-stay, hospital stay, cell saver blood transfusion, intra/postoperative blood transfusion, and postoperative TR.

Results The mean age was 67 ± 14.8 years, 45% were male. Mean EF was 47 ± 16.2%, postoperative 52 ± 12.4%. sPAP was 46 ± 20.1 mm Hg preoperatively, sPAP was 40.6 ± 9.4 mm Hg postoperatively, NA postoperatively was 12 ± 10 μg/min, NA peak was 18 ± 11 μg/min, operation time was 275 ± 92 minutes, CPB was 145 ± 49 minutes, ICU stay was 2.4 ± 2.4 days, hospital stay was 10.8 ± 3.5 days, cell saver blood transfusion was 736 ± 346 mL, intraoperative transfusions were 2.5 ± 1.6. Two patients needed postoperative transfusions. A total of 19 patients were extubated at the 1st postoperative day, 2 patients at the 2nd day, and 1 at the 4th postoperative day. Two patients required a pacemaker. No reintubation, no in-hospital mortality, and one reoperation because of bleeding complications.

Conclusion Correction of mild-to-moderate TR at the time of MV repair does maintain TV function and avoid right ventricular dysfunction in the early postoperative period improving the clinical outcome.

Keywords

tricuspid valve - mitral valve surgery - heart failure
 

  • References

  • 1 Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004; 43 (03) 405-409
    CrossrefPubMedGoogle Scholar
  • 2 Calafiore AM, Gallina S, Iacò AL. , et al. Mitral valve surgery for functional mitral regurgitation: should moderate-or-more tricuspid regurgitation be treated? A propensity score analysis. Ann Thorac Surg 2009; 87 (03) 698-703
    CrossrefPubMedGoogle Scholar
  • 3 Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair?. Ann Thorac Surg 2005; 79 (01) 127-132
    CrossrefPubMedGoogle Scholar
  • 4 Porter A, Shapira Y, Wurzel M. , et al. Tricuspid regurgitation late after mitral valve replacement: clinical and echocardiographic evaluation. J Heart Valve Dis 1999; 8 (01) 57-62
    PubMedGoogle Scholar
  • 5 Matsuyama K, Matsumoto M, Sugita T, Nishizawa J, Tokuda Y, Matsuo T. Predictors of residual tricuspid regurgitation after mitral valve surgery. Ann Thorac Surg 2003; 75 (06) 1826-1828
    CrossrefPubMedGoogle Scholar
  • 6 Matsunaga A, Duran CMG. Progression of tricuspid regurgitation after repaired functional ischemic mitral regurgitation. Circulation 2005; 112 (9, Suppl): I453-I457
    CrossrefPubMedGoogle Scholar
  • 7 Song H, Kim MJ, Chung CH. , et al. Factors associated with development of late significant tricuspid regurgitation after successful left-sided valve surgery. Heart 2009; 95 (11) 931-936
    CrossrefPubMedGoogle Scholar
  • 8 Kim JB, Yoo DG, Kim GS. , et al. Mild-to-moderate functional tricuspid regurgitation in patients undergoing valve replacement for rheumatic mitral disease: the influence of tricuspid valve repair on clinical and echocardiographic outcomes. Heart 2012; 98 (01) 24-30
    CrossrefPubMedGoogle Scholar
  • 9 Benedetto U, Melina G, Angeloni E. , et al. Prophylactic tricuspid annuloplasty in patients with dilated tricuspid annulus undergoing mitral valve surgery. J Thorac Cardiovasc Surg 2012; 143 (03) 632-638
    CrossrefPubMedGoogle Scholar
  • 10 Vahanian A, Alfieri O, Andreotti F. , et al; ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012; 42 (04) S1-S44
    CrossrefPubMedGoogle Scholar
  • 11 Nishimura RA, Otto CM, Bonow RO. , et al. AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129 (23) e521-643
    CrossrefPubMedGoogle Scholar
  • 12 Sagie A, Freitas N, Chen MH, Marshall JE, Weyman AE, Levine RA. Echocardiographic assessment of mitral stenosis and its associated valvular lesions in 205 patients and lack of association with mitral valve prolapse. J Am Soc Echocardiogr 1997; 10 (02) 141-148
    CrossrefPubMedGoogle Scholar
  • 13 Boyaci A, Gokce V, Topaloglu S, Korkmaz S, Goksel S. Outcome of significant functional tricuspid regurgitation late after mitral valve replacement for predominant rheumatic mitral stenosis. Angiology 2007; 58 (03) 336-342
    CrossrefPubMedGoogle Scholar
  • 14 Braunwald NS, Ross Jr J, Morrow AG. Conservative management of tricuspid regurgitation in patients undergoing mitral valve replacement. Circulation 1967; 35 )4, Suppl): I63-I69
    PubMedGoogle Scholar
  • 15 Chan V, Burwash IG, Lam BK. , et al. Clinical and echocardiographic impact of functional tricuspid regurgitation repair at the time of mitral valve replacement. Ann Thorac Surg 2009; 88 (04) 1209-1215
    CrossrefPubMedGoogle Scholar
  • 16 Lee JW, Song JM, Park JP, Lee JW, Kang DH, Song JK. Long-term prognosis of isolated significant tricuspid regurgitation. Circ J 2010; 74 (02) 375-380
    CrossrefPubMedGoogle Scholar
  • 17 Pinney SP. The role of tricuspid valve repair and replacement in right heart failure. Curr Opin Cardiol 2012; 27 (03) 288-295
    CrossrefPubMedGoogle Scholar
  • 18 Shah PM, Raney AA. Tricuspid valve disease. Curr Probl Cardiol 2008; 33 (02) 47-84
    CrossrefPubMedGoogle Scholar
  • 19 Tang GH, David TE, Singh SK, Maganti MD, Armstrong S, Borger MA. Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes. Circulation 2006; 114 (1, Suppl): I577-I581
    CrossrefPubMedGoogle Scholar
  • 20 Greyson CR. Right heart failure in the intensive care unit. Curr Opin Crit Care 2012; 18 (05) 424-431
    CrossrefPubMedGoogle Scholar
  • 21 Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008; 117 (13) 1717-1731
    CrossrefPubMedGoogle Scholar
  • 22 O'Rourke RA, Dell'Italia LJ. Diagnosis and management of right ventricular myocardial infarction. Curr Probl Cardiol 2004; 29 (01) 6-47
    CrossrefPubMedGoogle Scholar
  • 23 Sagie A, Schwammenthal E, Padial LR, Vazquez de Prada JA, Weyman AE, Levine RA. Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: Doppler color flow study of 109 patients. J Am Coll Cardiol 1994; 24 (02) 446-453
    CrossrefPubMedGoogle Scholar
  • 24 Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol 2009; 53 (05) 401-408
    CrossrefPubMedGoogle Scholar
  • 25 Singh SK, Tang GH, Maganti MD. , et al. Midterm outcomes of tricuspid valve repair versus replacement for organic tricuspid disease. Ann Thorac Surg 2006; 82 (05) 1735-1741 , discussion 1741
    CrossrefPubMedGoogle Scholar